L. Cestelli (Bergen, Norway), F. Schleich (Liège, Belgium)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Laryngeal dysfunction is predominant in asthmatic women treated by inhaled corticosteroids
N. Migueres (Strasbourg, France), C. Delmas (Saverne, France), J. Petit Thomas (Colmar, France), H. Kuntz (Strasbourg, France), E. Peri-Fontaa (Strasbourg, France), P. Schultz (Strasbourg, France), M. Velten (Strasbourg, France), F. De Blay (Strasbourg, France)
|   |
The cut-off values for Visual Analogue Scale (VAS) and for the Assessment Tool for Asthma (ATA) according the Control for Asthma and Allergic Rhinitis Test (CARAT)
D. ONGEL HARBIYELI (Istanbul, Turkey), B. Gemicioglu (Istanbul, Turkey), H. Ertem Vehid (Istanbul, Turkey), J. Bousquet (Berlin, Germany), J. Fonseca (Porto, Portugal), B. Gemicioglu (Istanbul, Turkey)
| |
Clinical characterization of T2 low phenotype
V. Carriero (Orbassano, Italy), A. Sprio (Orbassano, Italy), A. Baroso (Orbassano, Italy), G. Ciprandi (Genova, Italy), E. Riccardi (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
| |
Respiratory, cardiovascular and systemic factors associated with brain damage in Chronic Obstructive Pulmonary Disease (COPD) and/or coronary artery disease (CAD)
C. Spilling (London, United Kingdom), M. Dhillon (London, United Kingdom), D. Burrage (London, United Kingdom), S. Ruickbie (London, United Kingdom), E. Baker (London, United Kingdom), T. Barrick (London, United Kingdom), P. Jones (London, United Kingdom)
| |
Impact of cytokines on endothelium in COPD patients
O. Arkhipkina (Kharkiv, Ukraine)
| |
Clinical and functional characteristics of the natural course of COPD
S. Kotlyarov (Ryazan, Russian Federation)
| |
The nutritional status of COPD exacerbators
C. Rôlo Silvestre (Torres Vedras, Portugal), T. Dias Domingues (Lisboa, Portugal), M. Cavaco (Torres Vedras, Portugal), A. Nunes (Torres Vedras, Portugal), R. Cordeiro (Torres Vedras, Portugal), T. Silva Santos (Torres Vedras, Portugal), T. Falcão (Torres Vedras, Portugal), A. Domingos (Torres Vedras, Portugal)
| |
Inflammation and physical capacity in relation to clinical COPD clustering
S. Gagatek (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), M. Högman (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Study of gastroesophageal reflux disease in frequent exacerbations of chronic obstructive pulmonary disease
R. Khamitov (Kazan (Republic of Tatarstan), Russian Federation), A. Zinnatullina (Kazan (Republic of Tatarstan), Russian Federation)
| |
Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
F. Trudzinski (Heiderberg, Germany), C. Kellerer (Munich, Germany), R. Jörres (Munich, Germany), P. Alter (Marburg, Germany), J. Lutter (Munich, Germany), F. Trinkmann (Heidelberg, Germany), F. Herth (Heidelberg, Germany), M. Frankenberger (Munich, Germany), H. Watz (Groshansdorf, Germany), C. Vogelmeier (Merburg , Germany), H. Kauczor (Heidelberg, Germany), T. Welte (Hannover , Germany), J. Behr (Munich, Germany), R. Bals (Homburg, Germany), K. Kahnert (Munich , Germany)
| |
Admission due to heart failure and pulmonary function testing: is there a COPD?
N. Slepchenko (Vinnytsya, Ukraine), Y. Mostovoy (Vinnytsya, Ukraine), L. Rasputina (Vinnytsya, Ukraine), K. Dmytriiev (Vinnytsya, Ukraine)
| |
Clinical and inflammatory characteristics of never-, intermittent- and persistent-COPD exacerbators
J. Ellingsen (Uppsala, Sweden), C. Janson (Uppsala, Sweden), B. Ställberg (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden), K. Bröms (Gävle, Sweden), M. Högman (Uppsala, Sweden), H. Hedenström (Uppsala, Sweden), A. Malinovschi (Uppsala, Sweden)
| |
Is there a role of Heart Failure in pulmonary function testing?
N. Slepchenko (Vinnytsya, Ukraine), Y. Mostovoy (Vinnytsya, Ukraine), L. Rasputina (Vinnytsya, Ukraine), K. Dmytriiev (Vinnytsya, Ukraine)
| |
Clinical COPD Questionnaire results depending on the degree of the inflammatory response in patients with COPD combined with hypertension
A. Melenevych (Kharkiv, Ukraine)
| |
Prevalence of Anxiety Disorders and Depression in Patients with Chronic Obstructive Pulmonary Disease and correlation with the clinical stage of the disease
S. Stoshikj (Wien, Austria), J. Brugger (Wien, Austria), M. Idzko (Wien, Austria), D. Gompelmann (Wien, Austria)
| |
The prevalence of primary ciliary dyskinesia (PCD) in adult patients with bronchiectasis in Dnipro (Ukraine)
K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), V. Dmytrychenko (Dnipro, Ukraine)
| |
The international primary ciliary dyskinesia (PCD) registry reports genotype/phenotype-correlations
J. Raidt (Muenster, Germany), P. Pennekamp (Muenster, Germany), S. Riepenhausen (Muenster, Germany), H. Krenz (Muenster, Germany), S. Helms (Muenster, Germany), T. Nöthe-Menchen (Muenster, Germany), B. Dworniczak (Muenster, Germany), H. Olbrich (Muenster, Germany), N. Loges (Muenster, Germany), J. Große-Onnebrink (Muenster, Germany), M. Holgersen (Copenhagen, Denmark), J. Marthin (Copenhagen, Denmark), K. Nielsen (Copenhagen, Denmark), M. Dugas (Muenster, Germany), H. Omran (Muenster, Germany)
| |
A cross-sectional analysis of the burden of respiratory disease and engagement with the respiratory outpatient service amongst hospitalised patients referred to the social inclusion team
S. Green (Dublin, Ireland), E. Hunt (Dublin, Ireland), S. Miggins (Dublin, Ireland), T. Mc Ginty (Dublin, Ireland)
| |
Sub-glottic Stenosis: An orphan tracheopathy – a great asthma mimic!
S. Iftikhar (Stoke-on-trent, United Kingdom), A. Abi Musa Asa'Ari (Stoke-on-trent, United Kingdom), Q. Abdullah (Stoke-on-trent, United Kingdom), M. Abdelmoteleb (Stoke-on-trent, United Kingdom), S. Ghosh (Stoke-on-trent, United Kingdom), M. Haris (Stoke-on-trent, United Kingdom), Q. Abdullah (Stoke on trent, United Kingdom)
| |
Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
D. Buklioska Ilievska (Skopje), J. Minov (Skopje), I. Mickovski (Skopje), N. Kochovska Kamchevska (Skopje)
| |